Peptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence

The global market for peptide synthesis is expected to grow from $1.9 billion in 2026 to $2.59 billion by 2031. This expansion is fueled by increasing demand for peptide-based therapeutics and ongoing advancements in synthesis methods.
Key takeaways
- Peptide synthesis market projected to hit $2.59 billion by 2031
- Therapeutic applications are a primary growth driver
- Advanced synthesis technologies are enabling market expansion
- AI tools will be crucial for this expanding sector
Why it matters
This market growth indicates a rising need for sophisticated AI tools in drug discovery and development. Professionals in biotech and pharmaceuticals will likely see increased demand for AI assistants capable of complex molecular design and data analysis.
Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
- Zoom MarketingZoom Marketing offers AI-driven marketing automation tailored for SMBs, simplifying customer engagement and lead nurturing. It helps businesses grow with intelligent campaigns and insights.
- MarketMuseMarketMuse utilizes AI to analyze content performance and suggest improvements for SEO and content strategy. It helps create comprehensive, authoritative content that ranks high in search engines.
- Synthesia (Marketing)Synthesia empowers marketing teams to create personalized video content with AI avatars for various campaigns, including product announcements, lead generation, and customer onboarding. It allows for quick, cost-effective video production without traditional filming, making tailored messaging scalable. Perfect for enhancing brand communication.



